Pricing Log in Create free account
Friday 6 November 2026 Export LQDA’s income statement to Excel — free account

Liquidia Corporation

LQDA Healthcare Drug Manufacturers Specialty & Generic

Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.

Revenue
+1,842.7%
EPS
+271.4%
Free cash flow
+270.2%
Total debt
−9.04%

Quarter to June 2026, against a year earlier

44.69 2.69 −5.68%
Market cap
$4.0B
P/E
28.5×
Fwd P/E
22.1×
Dividend yield
—
F-score
5/9
Altman Z
4.08
Beneish M
6.79
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Liquidia Corporation (LQDA) Net margin

Alert me on Net margin

Liquidia Corporation's net margin over the twelve months to 30 June 2026 was 30.7%, up 74.3 percentage points from fiscal 2025 (−43.5%). Over the past ten years it has ranged from −8,080.4% (fiscal 2020) to −43.5% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of −2.45% and above the Healthcare sector median of 0.00%.

Net margin, annual

Embed this chart

Annual newest first

Period Net margin Change (points)
FY2025 −43.5% 873.10
FY2024 −916.6% (467.74)
FY2023 −448.9% (191.50)
FY2022 −257.4% 0.00
FY2022 −257.4% 11.64
FY2021 −269.0% (46.05)
FY2021 −223.0% 7,857.44
FY2020 −8,080.4% 0.00
FY2020 −8,080.4% (7,490.94)
FY2019 −589.5% 0.00

Quarterly newest first

Period Net margin Change (points)
Jun 2026 43.5% 3.73
Mar 2026 39.8% 23.97
Dec 2025 15.8% 22.32
Sep 2025 −6.50% 464.01
32 more quarters

Against its own ten years

Low −8,080.4% High −43.5%
Ten-year median −425.3%
Current reading's percentile 100

Net margin against peers

Company Net margin
SUPN Indivior Pharmaceuticals Inc. compare 32.9%
LQDA Liquidia Corporation 30.7%
LNTH Lantheus Holdings, Inc. compare 17.3%
PBH Prestige Consumer Healthcare Inc. compare 13.3%
AMRX AMNEAL PHARMACEUTICALS, INC. compare 4.17%
AMLX Amylyx Pharmaceuticals, Inc. compare 0.00%
RGC Regencell Bioscience Holdings Limited compare 0.00%
HIMS Hims & Hers Health, Inc. compare −5.51%
HCM HUTCHMED (China) Limited Sponsored ADR compare −23.6%
Drug Manufacturers Specialty & Generic industry median −2.45%
Healthcare sector median 0.00%
Market median 1.06%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on LQDA